blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2542058

EP2542058 - EFFECTIVE SENSITIZING DOSE OF A GELLED IMMUNOMODULATING TOPICAL COMPOSITION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.08.2019
Database last updated on 19.10.2024
FormerThe patent has been granted
Status updated on  07.09.2018
FormerGrant of patent is intended
Status updated on  15.08.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Phio Pharmaceuticals Corp.
257 Simarano Drive, Suite 101
Marlborough, MA 01752 / US
[2019/12]
Former [2018/20]For all designated states
RXi Pharmaceuticals Corporation
257 Simarano Drive, Suite 101
Marlborough, MA 01752 / US
Former [2013/02]For all designated states
Hapten Pharmaceuticals, LLC
20 Nassau St.
Suite 210
Princeton, NJ 08542 / US
Inventor(s)01 / LEVIS, William, R.
151 West 17th Street
New York NJ 10011 / US
02 / KAPLAN, Leonard, L.
1 Minute Man Court
East Brunswick NJ 08816 / US
03 / CALLAHAN, John, G.
212 Quakerbridge Court
Moorestown NJ 08057 / US
 [2013/02]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[2018/41]
Former [2013/02]Grünecker, Kinkeldey, Stockmair & Schwanhäusser
Leopoldstrasse 4
80802 München / DE
Application number, filing date11751116.225.02.2011
[2018/41]
WO2011US26310
Priority number, dateUS20100309717P02.03.2010         Original published format: US 309717 P
[2013/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011109248
Date:09.09.2011
Language:EN
[2011/36]
Type: A1 Application with search report 
No.:EP2542058
Date:09.01.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 09.09.2011 takes the place of the publication of the European patent application.
[2013/02]
Type: B1 Patent specification 
No.:EP2542058
Date:10.10.2018
Language:EN
[2018/41]
Search report(s)International search report - published on:US09.09.2011
(Supplementary) European search report - dispatched on:EP04.06.2014
ClassificationIPC:A01N35/00, A61K9/06, A61K9/10, A61K9/14, A61K9/26, A61K31/122, A61K47/14, A61K47/26, A61K47/10
[2017/35]
CPC:
A61K31/122 (EP,US); A61K47/10 (EP,US); A61K47/14 (EP,US);
A61K47/26 (EP,US); A61K9/0014 (EP,US); A61K9/06 (US);
A61P17/12 (EP); A61P31/20 (EP); A61P35/00 (EP) (-)
Former IPC [2014/27]A01N35/00, A61K9/06, A61K9/10, A61K9/14, A61K9/26, A61K31/122
Former IPC [2013/02]A01N35/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/02]
Extension statesBA01.10.2012
ME01.10.2012
TitleGerman:EFFEKTIVE SENSIBILISIERUNGSDOSIS EINER GELIERTEN TOPISCHEN IMMUNMODULATIONSZUSAMMENSETZUNG[2013/02]
English:EFFECTIVE SENSITIZING DOSE OF A GELLED IMMUNOMODULATING TOPICAL COMPOSITION[2013/02]
French:DOSE À EFFET SENSIBILISANT D'UNE COMPOSITION TOPIQUE IMMUNOMODULATRICE GÉLIFIÉE[2013/02]
Entry into regional phase01.10.2012National basic fee paid 
01.10.2012Search fee paid 
01.10.2012Designation fee(s) paid 
01.10.2012Examination fee paid 
Examination procedure01.10.2012Examination requested  [2013/02]
23.12.2014Amendment by applicant (claims and/or description)
14.04.2016Despatch of a communication from the examining division (Time limit: M04)
23.08.2016Reply to a communication from the examining division
16.08.2017Communication of intention to grant the patent
01.02.2018Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
04.04.2018Fee for grant paid
04.04.2018Fee for publishing/printing paid
04.04.2018Receipt of the translation of the claim(s)
Divisional application(s)EP18199082.1  / EP3494790
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.04.2016
Opposition(s)11.07.2019No opposition filed within time limit [2019/38]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
04.04.2018Request for further processing filed
04.04.2018Full payment received (date of receipt of payment)
Request granted
18.04.2018Decision despatched
Fees paidRenewal fee
27.02.2013Renewal fee patent year 03
12.02.2014Renewal fee patent year 04
25.02.2015Renewal fee patent year 05
26.02.2016Renewal fee patent year 06
27.02.2017Renewal fee patent year 07
27.02.2018Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU25.02.2011
AL10.10.2018
AT10.10.2018
CY10.10.2018
CZ10.10.2018
DK10.10.2018
EE10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
MC10.10.2018
MK10.10.2018
NL10.10.2018
PL10.10.2018
RO10.10.2018
RS10.10.2018
SE10.10.2018
SI10.10.2018
SK10.10.2018
SM10.10.2018
TR10.10.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
LU25.02.2019
MT25.02.2019
BE28.02.2019
[2022/31]
Former [2021/32]HU25.02.2011
AL10.10.2018
AT10.10.2018
CY10.10.2018
CZ10.10.2018
DK10.10.2018
EE10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
MC10.10.2018
NL10.10.2018
PL10.10.2018
RO10.10.2018
RS10.10.2018
SE10.10.2018
SI10.10.2018
SK10.10.2018
SM10.10.2018
TR10.10.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
LU25.02.2019
MT25.02.2019
BE28.02.2019
Former [2021/26]AL10.10.2018
AT10.10.2018
CY10.10.2018
CZ10.10.2018
DK10.10.2018
EE10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
MC10.10.2018
NL10.10.2018
PL10.10.2018
RO10.10.2018
RS10.10.2018
SE10.10.2018
SI10.10.2018
SK10.10.2018
SM10.10.2018
TR10.10.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
LU25.02.2019
MT25.02.2019
BE28.02.2019
Former [2020/29]AL10.10.2018
AT10.10.2018
CZ10.10.2018
DK10.10.2018
EE10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
MC10.10.2018
NL10.10.2018
PL10.10.2018
RO10.10.2018
RS10.10.2018
SE10.10.2018
SI10.10.2018
SK10.10.2018
SM10.10.2018
TR10.10.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
LU25.02.2019
MT25.02.2019
BE28.02.2019
Former [2020/17]AL10.10.2018
AT10.10.2018
CZ10.10.2018
DK10.10.2018
EE10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
MC10.10.2018
NL10.10.2018
PL10.10.2018
RO10.10.2018
RS10.10.2018
SE10.10.2018
SI10.10.2018
SK10.10.2018
SM10.10.2018
TR10.10.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
LU25.02.2019
BE28.02.2019
Former [2020/12]AL10.10.2018
AT10.10.2018
CZ10.10.2018
DK10.10.2018
EE10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
MC10.10.2018
NL10.10.2018
PL10.10.2018
RO10.10.2018
RS10.10.2018
SE10.10.2018
SI10.10.2018
SK10.10.2018
SM10.10.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
LU25.02.2019
BE28.02.2019
Former [2019/50]AL10.10.2018
AT10.10.2018
CZ10.10.2018
DK10.10.2018
EE10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
MC10.10.2018
NL10.10.2018
PL10.10.2018
RO10.10.2018
RS10.10.2018
SE10.10.2018
SI10.10.2018
SK10.10.2018
SM10.10.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
LU25.02.2019
Former [2019/47]AL10.10.2018
AT10.10.2018
CZ10.10.2018
DK10.10.2018
EE10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
MC10.10.2018
NL10.10.2018
PL10.10.2018
RO10.10.2018
RS10.10.2018
SE10.10.2018
SK10.10.2018
SM10.10.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
LU25.02.2019
Former [2019/45]AL10.10.2018
AT10.10.2018
CZ10.10.2018
DK10.10.2018
EE10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
MC10.10.2018
NL10.10.2018
PL10.10.2018
RO10.10.2018
RS10.10.2018
SE10.10.2018
SK10.10.2018
SM10.10.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
Former [2019/40]AL10.10.2018
AT10.10.2018
CZ10.10.2018
DK10.10.2018
EE10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
NL10.10.2018
PL10.10.2018
RO10.10.2018
RS10.10.2018
SE10.10.2018
SK10.10.2018
SM10.10.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
Former [2019/37]AL10.10.2018
AT10.10.2018
CZ10.10.2018
DK10.10.2018
EE10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
NL10.10.2018
PL10.10.2018
RO10.10.2018
RS10.10.2018
SE10.10.2018
SM10.10.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
Former [2019/35]AL10.10.2018
AT10.10.2018
CZ10.10.2018
DK10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
NL10.10.2018
PL10.10.2018
RS10.10.2018
SE10.10.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
Former [2019/34]AL10.10.2018
AT10.10.2018
DK10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
NL10.10.2018
PL10.10.2018
RS10.10.2018
SE10.10.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
Former [2019/26]AL10.10.2018
AT10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
LT10.10.2018
LV10.10.2018
NL10.10.2018
PL10.10.2018
RS10.10.2018
SE10.10.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
Former [2019/25]AT10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
LT10.10.2018
LV10.10.2018
NL10.10.2018
PL10.10.2018
RS10.10.2018
SE10.10.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
Former [2019/24]AT10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
LT10.10.2018
LV10.10.2018
NL10.10.2018
PL10.10.2018
SE10.10.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
Former [2019/23]AT10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
LT10.10.2018
LV10.10.2018
NL10.10.2018
PL10.10.2018
BG10.01.2019
NO10.01.2019
IS10.02.2019
Former [2019/22]FI10.10.2018
LT10.10.2018
NL10.10.2018
PL10.10.2018
BG10.01.2019
NO10.01.2019
IS10.02.2019
Former [2019/21]FI10.10.2018
LT10.10.2018
NL10.10.2018
NO10.01.2019
IS10.02.2019
Former [2019/20]LT10.10.2018
NL10.10.2018
NO10.01.2019
Former [2019/17]NL10.10.2018
Documents cited:Search[A]  - NAYLOR M F ET AL, "Contact immunotherapy of resistant warts", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY, INC, US, vol. 19, no. 4, doi:10.1016/S0190-9622(88)70222-4, ISSN 0190-9622, (19881001), pages 679 - 683, (19881001), XP023658611 [A] 1-11 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0190-9622(88)70222-4
International search[A]US6761900  (SHUDO JUTARO [US], et al);
 [Y]US2005260136  (KAPLAN LEONARD L [US], et al);
 [Y]US7067254  (KUMAMOTO TADASHI [JP], et al);
 [Y]US2006211766  (KAPLAN LEONARD L [US], et al);
 [Y]  - UPITIS JA ET AL., "The use of diphenylcyclopropenone in the treatment of recalcitrant warts", J CUTAN MED SURG 1203-4754, (2002), vol. 6, no. 3, pages 214 - 217, XP008168278

DOI:   http://dx.doi.org/10.1007/s10227-001-0050-9
 [Y]  - BUCKLEY DA ET AL., "The therapeutic use of topical contact sensitizers in benign dermatoses", BR J DERMATOL, (2001), vol. 145, no. 3, pages 385 - 405, XP055097072

DOI:   http://dx.doi.org/10.1111/j.1365-2133.2001.04399.x
by applicantUS2006211766
 US2010041767
    - LORINCZ ET AL., OBSTETRICS & GYNECOLOGY, (1992), vol. 79, pages 328 - 337
    - BEAUDENON ET AL., NATURE, (1986), vol. 321, pages 246 - 249
    - HOLLOWAY ET AL., GYNECOL. ONC., (1991), vol. 41, pages 123 - 128
    - FRAZER, GENITOURIN. MED., (1996), vol. 72, pages 398 - 403
    - VAN DRIEL ET AL., ANN. MED., (1996), vol. 28, pages 471 - 477
    - "Chapter 66: Papillomaviruses", SHAH ET AL., Virology, RAVEN PRESS, (1996), pages 2077 - 2109
    - HAUSEN, J., NATL. CANCER INST., (2000), vol. 92, pages 690 - 698
    - LEONG ET AL., SURG CLIN NORTH AM, (1996), vol. 76, pages 1355 - 81
    - BAKER ET AL., DERMATOLOGIC CLINICS, (1997), vol. 15, pages 331 - 340
    - JOHNSON ET AL., CONSULTANT, (1999), vol. 39, pages 253 - 266
    - SCORSKI ET AL., PROC. NATL. ACAD. SCI. USA, (1997), vol. 94, pages 3966 - 3971
    - DAMM ET AL., EMBO J., (2001), vol. 20, pages 6958 - 6968
    - KORN ET AL., ANNU REV IMMUNOL, (2009), vol. 27, page 485
    - ACOSTA-RODRIGUEZ ET AL., NAT IMMUNOL, (2007), vol. 8, page 942
    - WILSON ET AL., NAT IMMUNOL, (2007), vol. 8, page 950
    - YANG ET AL., NATURE, (2008), vol. 454, page 350
    - CHEN ET AL., IMMUNOL RES, (2008), vol. 41, page 87
    - MURANSKI ET AL., BLOOD, (2008), vol. 112, page 362
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.